Related Experiment Videos
[Intrathecal morphine administration for oral and maxillofacial malignomas]
J Schramm1, J Neidhardt, W Spitzer
1Neurochirurgische Universitatsklinik, Bonn.
Deutsche Zahnarztliche Zeitschrift
|January 1, 1990
Summary
Intraventricular morphine administration via a subcutaneous pump offers effective pain relief with fewer systemic side effects. This method provides a non-destructive option for medium-term pain management in advanced cancer patients, enabling comfort at home.
Area of Science:
- Oncology
- Pain Management
- Pharmacology
Context:
- Malignant tumors in the oropharyngeal region often cause severe, incurable pain.
- Advanced cancer patients require effective pain management strategies for improved quality of life.
- Traditional pain management may lead to significant systemic side effects.
Purpose:
- To evaluate the efficacy and safety of intraventricular morphine administration for oropharyngeal cancer pain.
- To explore the use of a subcutaneous pump for medium-term pain therapy in palliative care.
- To assess the potential for improved patient comfort and home-based care during terminal stages.
Summary:
- Intraventricular morphine administration through a subcutaneous pump significantly reduces systemic side effects compared to other routes.
- This approach provides highly satisfactory pain relief for patients with incurable pain from oropharyngeal malignancies.
- The morphine pump facilitates a non-destructive, medium-term pain management solution, allowing patients to remain at home.
Impact:
- Offers a viable alternative for medium-term pain control in advanced cancer patients.
- Enhances patient comfort and quality of life, especially during terminal phases.
- Enables patients to spend their final stages of illness at home in a familiar environment, well-relieved from pain.